Syncona
Growth equityLondon · Pre-Seed–Late Stage · 33 people tracked
Investment thesis
Syncona invests in leading life science companies developing transformational treatments across various therapeutic areas. The team combines deep technical scientific expertise with commercial experience in venture capital and pharmaceutical development, supporting the UK life science ecosystem and working closely with academics and co-investors.
Source: firm website, verified Jul 21, 2026.
Team · 33 people
from the firm's websiteInvestments · 30 tracked
founders shown can be your intro pathBiopharmaceutical company developing CAR T-cell therapies for blood cancers, with FDA approval for AUCATZYL® (obe-cel) for relapsed/refractory B-cell acute lymphoblastic leukemia.
Frequently asked questions
- What stage does Syncona invest at?
- Syncona invests at the Pre-Seed, Seed, Series A, Series B, Series C, Growth, Late Stage stages.
- What sectors does Syncona focus on?
- Syncona focuses on Biotech, Medical Devices.
- Where is Syncona located?
- Syncona is headquartered in London, GB.
Similar investors
B Capital is a venture capital firm managing over $12 billion in assets with a stage-based fund approach. The firm invests across early to late-stage companies in technology, healthcare, and energy & resilience sectors, with 200+ portfolio companies and 9 global offices.
DCVC is a deep tech venture capital firm with over a dozen years of experience backing entrepreneurs using computational approaches to solve trillion-dollar problems across industries including AI, climate, materials science, robotics, space, and biology.
A European investment firm established in 2016 by former Index Ventures life sciences professionals with over 20 years of experience in drug discovery and therapeutic development for unmet medical needs.
Osage University Partners is a venture capital firm founded in 2009 that invests in breakthrough startups emerging from leading research labs and university innovation ecosystems. The firm focuses on technology (software, hardware, climate tech) and life science (therapeutics, medtech, diagnostics, research tools) companies across all stages from pre-seed through crossover, leveraging partnerships with over 150 universities and research institutions globally.
F Prime Capital is an investment firm composed of scientists, engineers, physicians, operators, and investors who provide real-world expertise to help portfolio companies accelerate their path to scalable growth.